NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

微小病變:流行病學的洞察(2030年為止的預測)

Minimal Change Disease - Epidemiology Insight - 2030

出版商 DelveInsight Business Research LLP 商品編碼 966796
出版日期 按訂單生產 內容資訊 英文 100 Pages
商品交期: 10個工作天內
價格
微小病變:流行病學的洞察(2030年為止的預測) Minimal Change Disease - Epidemiology Insight - 2030
出版日期: 按訂單生產內容資訊: 英文 100 Pages
簡介

本報告提供世界主要7個國家(美國,歐洲5個國家(德國,法國,義大利,西班牙,英國),日本)的微小病變的相關調查,提供流行病學及預測,各市場區隔的病例,診斷案例等資訊。

目錄

第1章 主要洞察

第2章 摘要整理

第3章 疾病的背景和概要

  • 概要
  • 徵兆與症狀
  • 病理學
  • 危險因素
  • 診斷

第4章 患者的治療過程

第5章 流行病學和患者人口

  • 流行病學的主要調查結果
  • 前提條件與理論的根據:主要7個國家
  • 流行病學方案:主要7個國家
    • 流行病學方案(2017-2030)
  • 美國流行病學
  • 各流行病學歐洲5個國家
    • 德國流行病學
    • 法國流行病學
    • 義大利流行病學
    • 西班牙流行病學
    • 英國流行病學
  • 日本流行病學

第6章 治療流程,目前治療,及醫務

  • 治療和管理
  • 治療流程

第7章 KOL的見解

第8章 未滿足需求

第9章 附錄

  • 參考文獻
  • 報告的調查手法

第10章 DelveInsight的服務內容

第11章 免責聲明

第12章 關於DelveInsight

目錄
Product Code: DIEI1071

DelveInsight's 'Minimal Change Disease - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Minimal Change Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Minimal Change Disease Understanding

The DelveInsight Minimal Change Disease epidemiology report gives a thorough understanding of the Minimal Change Disease by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Minimal Change Disease in the US, Europe, and Japan. The report covers the detailed information of the Minimal Change Disease epidemiology scenario in seven major countries (US, EU5, and Japan).

Minimal Change Disease Epidemiology Perspective by DelveInsight

The Minimal Change Disease epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Minimal Change Disease epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Minimal Change Disease epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Minimal Change Disease Detailed Epidemiology Segmentation

The Minimal Change Disease epidemiology covered in the report provides historical as well as forecasted Minimal Change Disease epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Minimal Change Disease report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

  • The Minimal Change Disease report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Minimal Change Disease Epidemiology Report and Model provide an overview of the risk factors and global trends of Minimal Change Disease in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Minimal Change Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Minimal Change Disease
  • The report provides the segmentation of the Minimal Change Disease epidemiology

Report Highlights:

  • 11-Year Forecast of Minimal Change Disease epidemiology
  • 7MM Coverage
  • Total Cases of Minimal Change Disease
  • Total Cases of Minimal Change Disease according to segmentation
  • Diagnosed cases of Minimal Change Disease

KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Minimal Change Disease?
  • What are the key findings pertaining to the Minimal Change Disease epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Minimal Change Disease across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Minimal Change Disease?
  • What are the currently available treatments of Minimal Change Disease?

Reasons to buy:

  • The Minimal Change Disease Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Minimal Change Disease market
  • Quantify patient populations in the global Minimal Change Disease market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Minimal Change Disease therapeutics in each of the markets covered
  • Understand the magnitude of Minimal Change Disease population by its epidemiology
  • The Minimal Change Disease Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Executive Summary of Minimal Change Disease

3. Minimal Change Disease : Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Sign and Symptoms
  • 3.3. Pathophysiology
  • 3.4. Risk Factors
  • 3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

  • 5.1. Epidemiology Key Findings
  • 5.2. Assumptions and Rationale: 7MM
  • 5.3. Epidemiology Scenario: 7MM
    • 5.3.1. Minimal Change Disease Epidemiology Scenario in the 7MM (2017- 2030)
  • 5.4. United States Epidemiology
    • 5.4.1. Minimal Change Disease Epidemiology Scenario in the United States (2017- 2030)
  • 5.5. EU-5 Country-wise Epidemiology
    • 5.5.1. Germany Epidemiology
      • 5.5.1.1. Minimal Change Disease Epidemiology Scenario in Germany (2017- 2030)
    • 5.5.2. France Epidemiology
      • 5.5.2.1. Minimal Change Disease Epidemiology Scenario in France (2017- 2030)
    • 5.5.3. Italy Epidemiology
      • 5.5.3.1. Minimal Change Disease Epidemiology Scenario in Italy (2017- 2030)
    • 5.5.4. Spain Epidemiology
      • 5.5.4.1. Minimal Change Disease Epidemiology Scenario in Spain (2017- 2030)
    • 5.5.5. United Kingdom Epidemiology
      • 5.5.5.1. Minimal Change Disease Epidemiology Scenario in the United Kingdom (2017-2030)
  • 5.6. Japan Epidemiology
    • 5.6.1. Minimal Change Disease Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

  • 6.1. Minimal Change Disease Treatment and Management
  • 6.2. Minimal Change Disease Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

The table of contents is not exhaustive; will be provided in the final report

List of Tables

  • Table 1: Minimal Change Disease Epidemiology in 7MM (2017-2030)
  • Table 2: Minimal Change Disease Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Table 3: Minimal Change Disease Epidemiology in the United States (2017-2030)
  • Table 4: Minimal Change Disease Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5: Minimal Change Disease Epidemiology in Germany (2017-2030)
  • Table 6: Minimal Change Disease Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7: Minimal Change Disease Epidemiology in France (2017-2030)
  • Table 8: Minimal Change Disease Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9: Minimal Change Disease Epidemiology in Italy (2017-2030)
  • Table 10: Minimal Change Disease Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11: Minimal Change Disease Epidemiology in Spain (2017-2030)
  • Table 12: Minimal Change Disease Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13: Minimal Change Disease Epidemiology in the United Kingdom (2017-2030)
  • Table 14: Minimal Change Disease Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Table 15: Minimal Change Disease Epidemiology in Japan (2017-2030)
  • Table 16: Minimal Change Disease Diagnosed and Treatable Cases in Japan (2017-2030)

List of Figures

  • Figure 1: Minimal Change Disease Epidemiology in 7MM (2017-2030)
  • Figure 2: Minimal Change Disease Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Figure 3: Minimal Change Disease Epidemiology in the United States (2017-2030)
  • Figure 4: Minimal Change Disease Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5: Minimal Change Disease Epidemiology in Germany (2017-2030)
  • Figure 6: Minimal Change Disease Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7: Minimal Change Disease Epidemiology in France (2017-2030)
  • Figure 8: Minimal Change Disease Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9: Minimal Change Disease Epidemiology in Italy (2017-2030)
  • Figure 10: Minimal Change Disease Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11: Minimal Change Disease Epidemiology in Spain (2017-2030)
  • Figure 12: Minimal Change Disease Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13: Minimal Change Disease Epidemiology in the United Kingdom (2017-2030)
  • Figure 14: Minimal Change Disease Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Figure 15: Minimal Change Disease Epidemiology in Japan (2017-2030)
  • Figure 16: Minimal Change Disease Diagnosed and Treatable Cases in Japan (2017-2030)

The table of contents is not exhaustive; will be provided in the final report